PZ Cussons PLC

Board/Management Information • Sep 29, 2025

National Storage Mechanism | Additional information

RNS Number : 1075B

PZ CUSSONS PLC

29 September 2025

29 September 2025

PZ CUSSONS PLC

BOARD CHANGE

PZ Cussons plc ("PZ Cussons" or the "Company") announces that Sarah Pollard, the Company's Chief Financial Officer, will be leaving the business and stepping down from the Board to take up a new role. 

Jonathan Myers, Chief Executive Officer, said: 

"I want to thank Sarah for everything she has done in nearly five years with PZ Cussons. She has been a key member of the leadership team and has helped navigate the business through an important phase of its development. Along with everyone at PZ Cussons, I wish her all the very best for the next chapter in her career." 

We will announce details of Sarah's replacement and her departure date in due course.

For further information please contact:

Investors

Simon Whittington - IR and Corporate Development Director      +44 (0) 77 1137 2928

Media

Headland [email protected]                       +44 (0) 20 3805 4822

Susanna Voyle, Stephen Malthouse, Charlie Twigg

Notes to editors

About PZ Cussons

PZ Cussons is a listed consumer goods business headquartered in Manchester, UK. We employ just under 2,500 people across our operations in Europe, North America, Asia-Pacific and Africa. Since our founding in 1884, we have been creating products to delight, care for and nourish consumers. Across our core categories of Hygiene, Baby and Beauty, our trusted and well-loved brands include Carex, Childs Farm, Cussons Baby, Imperial Leather, Morning Fresh, Original Source, Premier, Sanctuary Spa and St.Tropez. Sustainability and the wellbeing of our employees and communities everywhere are at the heart of our business model and strategy, and captured by our purpose: For everyone, for life, for good.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BOAPKFBQOBKDNCB